Hamza Hashmi, MD

Memorial Sloan Kettering Cancer Center

Latest Videos

Two medical professionals discussing Talquetamab monitoring and management strategies in an urban park setting.

Hematology

06/20/2026

Talquetamab Side Effects: Management and Counseling Strategies

Sawyer Bawek, DOHamza Hashmi, MD

Two medical professionals, Sawyer Bawek and Hamza Hashmi, discuss Teclistamab in earlier treatment lines for multiple myeloma with a city skyline background.

Hematology

06/17/2026

MajesTEC-9 Data and Teclistamab in Earlier Treatment Lines for Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD

Two medical professionals, Sawyer Bawek DO and Hamza Hashmi MD, discuss the evolution of CAR T-cell therapy against a cityscape background.

Hematology

06/16/2026

The Growing Role of CAR T-Cell Therapies in Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD

Experts discussing targeted therapy strategies for managing toxicities in multiple myeloma treatment, featuring Dr. Hamza Hashmi, Dr. Cesar Rodriguez, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Hematology

05/20/2026

Bispecific Therapy in Multiple Myeloma: Strategies for Managing Toxicities

Hamza Hashmi, MDCesar Rodriguez, MDRahul Gosain, MD, MBARohit Gosain, MD

Multimodal image featuring two doctors discussing cellular therapy for multiple myeloma, with cityscape background, emphasizing oncology research, CAR T-cell therapy, bispecific antibodies, and personalized cancer care advancements.

Multiple Myeloma

01/16/2026

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

Hamza Hashmi, MDShreyas Kalantri, MD

Early use of bispecific antibodies and CAR T strategies in relapsed multiple myeloma, discussed by experts Hamza Hashmi, MD, and Robert Orlowski, MD, PhD, with a cityscape background.

Multiple Myeloma

01/03/2026

Bispecific Antibodies and CAR T Redefine Early-Line Treatment in Multiple Myeloma

Robert Orlowski, MD, PhDHamza Hashmi, MD